MCG - Pharmacy Department - University of Parma, V.le G. P. Usberti 27/A - Campus Universitario, Parma, Italy

    Recent Publications

Epidermal Growth Factor Receptor Irreversible Inhibitors: Chemical Exploration of the Cysteine-Trap Portion.

Carmi C, Lodola A, Rivara S, Vacondio F, Cavazzoni A, Alfieri RR, Ardizzoni A, Petronini PG, Mor M.

Mini Rev Med Chem. 2011 Aug 24.

Application of Computational Methods to the Design of Fatty Acid Amide Hydrolase (FAAH) Inhibitors Based on a Carbamic Template Structure.

Lodola A, Rivara S, Mor M.

Adv Protein Chem Struct Biol. 2011;85:1-26.

Molecular dynamics simulations and docking studies on 3D models of the heterodimeric and homodimeric 5-HT(2A) receptor subtype.

Bruno A, Beato C, Costantino G.

Future Med Chem. 2011 Apr;3(6):665-81.

Covalent inhibitors of Fatty Acid amide hydrolase: a rationale for the activity of piperidine and piperazine aryl ureas.

Palermo G, Branduardi D, Masetti M, Lodola A, Mor M, Piomelli D, Cavalli A, De Vivo M.

J Med Chem. 2011 Oct 13;54(19):6612-23.

Understanding the role of carbamate reactivity in fatty acid amide hydrolase inhibition by QM/MM mechanistic modelling.

Lodola A, Capoferri L, Rivara S, Chudyk E, Sirirak J, Dyguda-Kazimierowicz E, Andrzej Sokalski W, Mileni M, Tarzia G, Piomelli D, Mor M, Mulholland AJ.

Chem Commun (Camb). 2011 Mar 7;47(9):2517-9. 

Bivalent ligand approach on N-{2-[(3-methoxyphenyl)methylamino]ethyl}acetamide: synthesis, binding affinity and intrinsic activity for MT(1) and MT(2) melatonin receptors.

Spadoni G, Bedini A, Orlando P, Lucarini S, Tarzia G, Mor M, Rivara S, Lucini V, Pannacci M, Scaglione F.

Bioorg Med Chem. 2011 Aug 15;19(16):4910-6.

Catalytic, asymmetric hypervinylogous Mukaiyama aldol reactions of extended furan-based silyl enolates.

Curti C, Battistini L, Sartori A, Lodola A, Mor M, Rassu G, Pelosi G, Zanardi F, Casiraghi G.

Org Lett. 2011 Sep 2;13(17):4738-41.

Biphenyl-3-yl alkylcarbamates as fatty acid amide hydrolase (FAAH) inhibitors: steric effects of N-alkyl chain on rat plasma and liver stability.

Vacondio F, Silva C, Lodola A, Carmi C, Rivara S, Duranti A, Tontini A, Sanchini S, Clapper JR, Piomelli D, Tarzia G, Mor M.

Eur J Med Chem. 2011 Sep;46(9):4466-73.  

Liquid chromatography-mass spectrometric method for determination of the non-imidazole H3-receptor antagonist UPR1056 in rat plasma.

Vacondio F, Silva C, Morini G, Bordi F, Flammini L, Barocelli E, Mor M.

J Sep Sci. 2011 Jul;34(14):1656-63. doi: 10.1002/jssc.201000845.

Extending SAR of bile acids as FXR ligands: discovery of 23-N-(carbocinnamyloxy)-3α,7α-dihydroxy-6α-ethyl-24-nor-5β-cholan-23-amine.

Gioiello A, Macchiarulo A, Carotti A, Filipponi P, Costantino G, Rizzo G, Adorini L, Pellicciari R.

Bioorg Med Chem. 2011 Apr 15;19(8):2650-8.

Application of a SCC-DFTB QM/MM approach to the investigation of the catalytic mechanism of fatty acid amide hydrolase.

Capoferri L, Mor M, Sirirak J, Chudyk E, Mulholland AJ, Lodola A.

J Mol Model. 2011 Sep;17(9):2375-83. 

Managed by Alessio Lodola

[ Home ] [ People ] [ News ] [ Events ] [ Research ] [ Publications ] [ Teaching ] [ Facilities ] [ Web Links ]

 
Last update: 10-17-11